Safety of Percutaneous Thermal Ablation of Lung Tumours in Pulmonary Hypertension
We were unable to detect a difference in safety profile between patients with and without PH who underwent percutaneous thermal ablation of lung tumours. However, frequencies of adverse outcomes were numerically higher in patients with PH.
Authors
- Stuart G. Silverman (ORCID: https://orcid.org/0000-0001-9461-8028)
- Alexander Warren Alessi
- Alexander Graur (ORCID: https://orcid.org/0000-0001-8149-461X)
- Florian J. Fintelmann (ORCID: https://orcid.org/0000-0002-0119-3903)
- Paul B. Shyn (ORCID: https://orcid.org/0000-0003-0538-2151)
- Jerome A. Westphal
- Behrooz Masuodi
- Josanna Rodriguez‐Lopez (ORCID: https://orcid.org/0000-0003-2637-0563)
- Michael Lanuti (ORCID: https://orcid.org/0000-0001-6049-1276)
- David C Moscho
Institutions
- University of North Carolina at Chapel Hill (US)
- Brigham and Women's Hospital (US)
- Massachusetts General Hospital (US)
Publication Details
- Journal
- European Journal of Cardio-Thoracic Surgery
- Published
- 2025-09-25
- DOI
- https://doi.org/10.1093/ejcts/ezaf312
- Primary Topic
- Hepatocellular Carcinoma Treatment and Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00